Does clinical response equate good #HRQoL in #SLE? Dr Gomez analysed responders in #belimumab trials and showed up to 29% pts reported poor SF-36 (esp physical aspects). Physical functioning & fatigue improved with therapy #EULAR2021 #POS0101 @RheumNow https://t.co/IU1k0UetEx